Final results of randomized phase II trial of metronomic vs weekly oral vinorelbine (OV) as first-line chemotherapy (CT) in advanced NSCLC patients unfit to platinum-based CT (P-CT): Tempo-Lung

This article has no abstract
Epistemonikos ID: 751f1805cbdd7f696c45a7aa7d7dedbc4f30ff31
First added on: Feb 11, 2025